Doug Godshall
Director
Nanotechnology
pSivida
Australia
Biography
Doug Godshall brings to pSidiva extensive experience and expertise in the medical device area. He was most recently the Chief Executive Officer and a Director of HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure. Under Mr. Godshall’s leadership, HeartWare was acquired by Medtronic in a deal valued at over $1 billion. Mr. Godshall joined HeartWare in 2006 from Boston Scientific Corporation where he worked for 16 years in various executive and leadership positions including President of the Vascular Surgery Division. He was also a member of Boston Scientific’s Operating Committee, and served as Vice President, Business Development where he oversaw more than 70 transactions including several strategic investments in the Ophthalmology arena.
Research Interest
Vascular Surgery Division
